Keywords: Recordati, Financial results 2012
Italy's Recordati posts solid 2012 result, as sales rise 8.7%
Article | 12 February 2013
Italian drugmaker Recordati (RC: MI) yesterday posted financial results for 2012, with consolidated revenue rising 8.7% to 828.3 million euros ($1.12 billion). Pharmaceutical sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
